Skip to main content

Table 4 Independent predictors of 30-day mortality in patients with suspected VAP

From: Impact of prior statin therapy on the outcome of patients with suspected ventilator-associated pneumonia: an observational study

  Hazard ratio 95% CI P
Steroids during VAP 1.93 1.25-2.98 <0.01
Cirrhosis 3.72 1.83-4.31 <0.01
Age 1.02 1.01-1.04 <0.01
SAPS II 1.02 1.01-1.04 <0.01
SOFA day 1 1.15 1.07-1.23 <0.01
Statin prior exposure 1.23 0.79-1.90 0.36
  1. VAP, ventilator-associated pneumonia; CI, confidence interval; SAPS II, simplified acute physiology score II; SOFA, sequential organ failure assessment.